Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Myeloid Leukemia
Study results from Technical University of Dresden provide new insights into acute myeloid leukemia
December 30th, 2008
According to recent research published in the Journal of Clinical Oncology, " In patients with acute myeloid leukemia (AML), differential indications for matched sibling and unrelated hematopoietic stem-cell transplantation (HCT) are considered, and arbitrary age limits for HCT exist. We sought to determine whether donor type is a prognostic factor in elderly patients in the era of high-resolution DNA-based HLA typing." "Patients and Methods We performed univariate and multivariate analyses of event-free survival (EFS) and overall survival (OS) in patients older than 50 years with standard-or high-risk AML who had received an allogeneic HCT between 1995 and 2005....
Source: Cancer Weekly (2008-12-30)
|
